Nanobiosym R&D Incubator Awarded FDA Contract to Demonstrate its Next-Gen Digital Dx™ Platform

Pioneering decentralized, high-resolution molecular diagnostics, longitudinal patient monitoring, & RWD/RWE generation for precision medicine.

OUR VALUES

abhayam

Fearlessness

The confidence to boldly enter unforseen markets and transcend boundaries between conventional disciplines.
achapalam

Focus

We focus our energy on the science, technology, and enterprises that can create the greatest impact on our planet.
arjavam

Transparency of Character

Straightforwardness — Acting all times in tune with our personal mission, corporate mission and our broader global mission.
dhriti

Steadfastness

The ability to withstand daily undulations in hypergrowth environments and volatile markets and venture into the new markets with steady, unwavering determination against the winds of resistance.
tapas

Self-discipline

The relentless quest to infuse efficiency, precision, and excellence into everything we do.
satya

Truthfulness

We strive to be true to ourselves, at all times. We will never rest on our laurels, but continuously strive to grow further.
tyaga

Renunciation

We seek to create long term sustainable impact.

Videos

THE LESSON: What was the lesson that changed your life?

Join the nbs^® ecosystem

To inquire about NBS^® Consulting Services or join our Global Ecosystem, email us at info@nanobiosym.com

Featured news and events

Order a Test Now

Decentralizing the
Next Generation of Healthcare^1,2

Featured In:

1. Precision Mobile Testing Is Key to Opening the Economy Safely
2. WorldViewpoint: How Nanobiophysics Will Transform Global Healthcare

Featured news and events

Sunday, 26 December 2021

Nanobiosym awarded the Gold Medal in the 2021 Entrepreneurship Sports Generation Global Competition

We at Nanobiosym are delighted and honored to be awarded the Gold Medal in the latest Entrepreneurship Sports Generation Global Competition and thank Shiv Khemka and ESG for their gracious support and encouragement of our mission to decentralize, personalize, and mobilize the next generation of healthcare on a Global level for 8 Billion citizens.

READ MORE
Monday, 19 July 2021

How might the COVID-19 pandemic end?

Nanobiosym CEO Dr. Anita Goel, MD, PhD and other world experts propose new solutions to end the pandemic.

READ MORE
Monday, 11 January 2021

Nanobiosym Featured in The Atlantic by Barclays Investment Bank

We are truly honored to be featured in The Atlantic by the Chairman of Barclays Investment Bank Read the full article: https://www.theatlantic.com/sponsored/barclays-unreasonable-group-2020/entrepreneurship-force-good/3553/

READ MORE
Thursday, 17 September 2020

GeneRadar® Displayed in the Smithsonian Design Museum

Nanobiosym CEO Dr. Anita Goel explains how GeneRADAR works, and its implications for the future of healthcare. This video is part of the "Tools" exhibition at Cooper Hewitt, Smithsonian Design Museum.

READ MORE
Tuesday, 07 July 2020

Unreasonable Impact COVID-19 Response Global Summit, created with Barclays

Nanobiosym Diagnostics was just selected as the winner in a worldwide competition led by Barclay’s Bank and the Unreasonable Group for a grant award to the Top Ten Companies in the World who are bringing world-changing solutions to the COVID crisis. The awards will be presented by Arianna Huffington on July 8.

READ MORE
Wednesday, 27 May 2020

Precision Mobile Testing Is Key to Opening the Economy Safely

Fighting COVID-19 with our antiquated paradigm of centralized health care delivery is like fighting World War III with a musket

READ MORE